Ventricular tachycardia syndromes

Med Clin North Am. 2001 Mar;85(2):267-304. doi: 10.1016/s0025-7125(05)70316-3.

Abstract

Better understanding of the underlying mechanism and substrate of different VTs has made it possible to tailor treatment strategies properly. The advent of sophisticated device-based therapy and of more precise and effective catheter ablation approaches will expand clinicians' ability to gain control of this multifaceted arrhythmia syndrome.

Publication types

  • Review

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use
  • Cardiomyopathies / complications
  • Catheter Ablation
  • Coronary Disease / complications
  • Diagnosis, Differential
  • Humans
  • Incidence
  • Prognosis
  • Risk Factors
  • Survival Rate
  • Syndrome
  • Tachycardia, Ventricular* / diagnosis
  • Tachycardia, Ventricular* / epidemiology
  • Tachycardia, Ventricular* / etiology
  • Tachycardia, Ventricular* / therapy
  • United States / epidemiology

Substances

  • Anti-Arrhythmia Agents